Anthropic IPO Outlook: The $2 Trillion Valuation Debate and Mysterious Trust Structure
nashnova research
Anthropic is moving toward an IPO at a rumored valuation above $2 trillion, but economists warn that figure would require over $120 billion in annual net profit by 2030 — and a never-disclosed trust quietly controls the board majority, leaving public shareholders with far less power than the price tag implies.
What does it actually take to justify a $2 trillion valuation?
Economist David Woo notes that $2 trillion rivals the market caps of TSMC and Meta — companies earning tens of billions annually behind deep competitive moats.
By his math, Anthropic would need annual net profit exceeding $120 billion by 2030. At a 10% net margin, that means roughly $1.22 trillion in annual revenue.
This means → Anthropic would have to capture nearly 30% of global software and IT services spending — an extraordinarily aggressive assumption given direct competition from OpenAI, Google, and others.
Is there a different framework that could make the number work?
LangChain CEO Harrison Chase offers an alternative lens: the key variable is how much enterprises will pay for AI agents.
If AI-agent spending equals just 5% of engineer costs, the $2 trillion valuation looks stretched. If it reaches 300%, the valuation could prove conservative.
In plain terms = the two experts are really debating one question: is AI a "cost-saving tool" or a "new species of labor"? The answer you pick changes the math completely.
What is the "Long-Term Benefit Trust," and why does it matter more than the valuation?
Anthropic has established a body called the Long-Term Benefit Trust. Its governance documents have never been publicly disclosed.
The trust can appoint four of seven board members — and remove them without cause. In plain terms = whoever controls the board majority controls the company's steering wheel.
Some legal experts argue this structure amounts to a de facto veto. An Anthropic spokesperson denied the trust holds veto power but offered no further detail.
Who sits behind the trust, and are they financially tied to the company?
Current trustees include former Federal Reserve Chair Ben Bernanke and Clinton Health Access Initiative head Neil Buddy Shah.
Anthropic says the trustees hold no equity and receive no profit share — they are compensated only for time and service.
This reflects a deliberate "firewall" design — shielding the company's public-benefit mission from shareholder pressure to maximize returns.
What is the real risk for anyone buying Anthropic stock?
Anthropic is a public benefit corporation (PBC) — a legal form that puts social mission ahead of shareholder returns. The trust exists to enforce that priority.
This means → even if you buy Anthropic shares, your influence over major decisions may be extremely limited — the trust-controlled board is the real decision-maker.
Put simply = the valuation debate is the visible issue; the governance structure is the hidden risk. You may be paying a $2 trillion price for what is essentially a passenger seat with no steering wheel.
市场有风险，内容仅供研究参考，不构成投资建议。